$IRD
Opus Genetics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Durham, NC
IRD chart
What traders are saying about $IRD
Latest postsOpus Genetics, Inc. news
- Opus Genetics Reports Q3 Loss of $46.5 Million or ($0.46) per Sh
GuruFocus ·
- Opus Genetics Inc reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029
Pluang ·
- Opus Genetics earnings missed by $0.32, revenue fell short of estimates
Investing.com India ·
- Opus Genetics Q3 Results: Loss widens to $(0.46), revenue falls 63%
scanx.trade ·
- Opus Genetics misses Q3 estimates on revenue and earnings
Investing.com ·
- Opus Genetics, Inc. (IRD) Misses Q3 EPS by 32c
StreetInsider ·
- Opus Genetics, Inc. (IRD) Reports Q3 Loss, Lags Revenue Estimates
Yahoo Finance ·
- Opus Genetics Q3 revenue falls and misses analyst estimates
TradingView ·
- IRD: Opus Genetics Inc. filed SEC Form 8-K: Results of Operations...
Quantisnow ·
- Opus Genetics Posts $46.5 Million Third-Quarter Net Loss
Quiver Quantitative ·
- Opus Genetics Announces Financial Results for Third Quarter 2026 and Provides Corporate Update
Yahoo Finance ·
Opus Genetics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $14.2M | $11.0M | $19.0M | $39.9M |
| Net income | -$49.6M | -$57.5M | -$10.0M | $17.9M |
| Diluted EPS | $-0.80 | $-2.15 | $-0.46 | $0.87 |
| Total assets (year end) | $50.2M | $36.9M | $53.9M | $49.0M |
| Cash and equivalents (year end) | $45.1M | $30.3M | $50.5M | $42.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Opus Genetics, Inc.
- Ticker
- IRD (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Durham, NC
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1228627
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC
Frequently asked questions
What exchange is Opus Genetics, Inc. listed on?
Opus Genetics, Inc. trades on the Nasdaq under the ticker symbol IRD.
What industry is Opus Genetics, Inc. in?
Opus Genetics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Opus Genetics, Inc. headquartered?
Opus Genetics, Inc.'s business address on file with the SEC is in Durham, NC.
When does Opus Genetics, Inc.'s fiscal year end?
Opus Genetics, Inc.'s fiscal year ends on December 31.
How much revenue did Opus Genetics, Inc. report?
Opus Genetics, Inc. reported $14.2M in revenue for calendar year 2025, according to its SEC filings.